Ernexa Therapeutics is headquartered in Cambridge, Massachusetts.
Ernexa Therapeutics is a life science company.
Ernexa Therapeutics was founded in 2018 .
1035 Cambridge Street Suite 18A,
Cambridge, Massachusetts
02141
United States,
(212) 582-1199
www.ernexatx.com
Ernexa Therapeutics is focused on providing cytokine-based therapy to treat patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Its most advanced program is studying the safety and efficacy of IRX-2 in patients with head and neck cancer. Ernexa Therapeutics was founded in 2018 and is based in Cambridge, Massachusetts.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | 2 | 1 | - | - | - | - | 3 |
| vol | $125M | $125M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 3 | ||||||||
| Financial | Deals |
|---|---|
|
Maxim Group |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
